nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of plasma cell neoplasm-associated chronic neutrophilic leukemia with ASXL1 and JAK2V617F mutations
|
Lauw, Marietya I. S. |
|
|
101 |
8 |
p. 1879-1881 |
artikel |
2 |
Acquired hemophilia A following allogeneic stem cell transplantation for acute lymphoblastic leukemia
|
Uminski, Kelsey |
|
|
101 |
8 |
p. 1861-1863 |
artikel |
3 |
Adverse events in lymphoma patients treated with phosphoinositide 3 kinase Inhibitor in clinical trials: a meta-analysis
|
Shan, Weihang |
|
|
101 |
8 |
p. 1741-1753 |
artikel |
4 |
A multicentre trial of intensive immunosuppressive therapy combined with umbilical cord blood for the treatment of severe aplastic anaemia
|
Zhou, Fang |
|
|
101 |
8 |
p. 1785-1794 |
artikel |
5 |
A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes
|
Sekeres, Mikkael A. |
|
|
101 |
8 |
p. 1689-1701 |
artikel |
6 |
Autoimmune basal ganglia encephalitis with hemolytic anemia
|
Werner, Ralph |
|
|
101 |
8 |
p. 1857-1858 |
artikel |
7 |
Autologous hematopoietic stem cell transplantation followed by interleukin-2 for adult acute myeloid leukemia patients with favorable or intermediate risk after complete remission
|
Zeng, Qiang |
|
|
101 |
8 |
p. 1711-1718 |
artikel |
8 |
Bilateral deafness in NK/T-cell lymphoma: EBV DNA prevailed over magnetic resonance imaging
|
Ho, Ryan C. W. |
|
|
101 |
8 |
p. 1853-1856 |
artikel |
9 |
Central nervous system relapse of acute promyelocytic leukemia treated by oral Venetoclax with Azacitidine achieved complete remission
|
Li, Yanling |
|
|
101 |
8 |
p. 1865-1867 |
artikel |
10 |
Comparable clinical outcomes of haploidentical hematopoietic stem cell transplantation in patients with hepatitis-associated aplastic anemia and non-hepatitis-associated aplastic anemia
|
Ma, Xiaodi |
|
|
101 |
8 |
p. 1815-1823 |
artikel |
11 |
Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate
|
Krečak, Ivan |
|
|
101 |
8 |
p. 1885-1886 |
artikel |
12 |
Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematologica Pugliese’
|
Mele, G. |
|
|
101 |
8 |
p. 1727-1739 |
artikel |
13 |
Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases
|
Rotterdam, Jil |
|
|
101 |
8 |
p. 1825-1834 |
artikel |
14 |
Efficacy and safety of nelarabine in patients with relapsed or refractory T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis
|
Kathpalia, Meghavi |
|
|
101 |
8 |
p. 1655-1666 |
artikel |
15 |
Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)
|
Zama, Daniele |
|
|
101 |
8 |
p. 1843-1851 |
artikel |
16 |
Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies
|
Taenaka, Ryutaro |
|
|
101 |
8 |
p. 1877-1878 |
artikel |
17 |
L-glutamine for sickle cell disease: more than reducing redox
|
Jafri, Firas |
|
|
101 |
8 |
p. 1645-1654 |
artikel |
18 |
Multiple-day administration of fosaprepitant combined with tropisetron and olanzapine improves the prevention of nausea and vomiting in patients receiving chemotherapy prior to autologous hematopoietic stem cell transplant: a retrospective study
|
Ye, Peipei |
|
|
101 |
8 |
p. 1835-1841 |
artikel |
19 |
Oncology stewardship in acute myeloid leukemia
|
Ochs, Madeleine A. |
|
|
101 |
8 |
p. 1627-1644 |
artikel |
20 |
Outcome prediction of chronic myeloid leukemia (CML) in children
|
Leung, Wing-Yan |
|
|
101 |
8 |
p. 1677-1688 |
artikel |
21 |
Prevalence and characteristics of inflammatory rheumatic diseases in patients with thalassemia
|
Piriyakhuntorn, Pokpong |
|
|
101 |
8 |
p. 1667-1675 |
artikel |
22 |
Relapse surveillance of acute myeloid leukemia patients in first remission after consolidation chemotherapy: diagnostic value of regular bone marrow aspirations
|
Koschade, Sebastian E. |
|
|
101 |
8 |
p. 1703-1710 |
artikel |
23 |
Resource utilization for chimeric antigen receptor T cell therapy versus autologous hematopoietic cell transplantation in patients with B cell lymphoma
|
Ring, Alexander |
|
|
101 |
8 |
p. 1755-1767 |
artikel |
24 |
Richter’s syndrome in central nervous system with MYD88L265P and CD79b mutation responded well to ibrutinib containing chemotherapy: a case report and review of the literature
|
Wang, Wei |
|
|
101 |
8 |
p. 1869-1872 |
artikel |
25 |
Risk factors for adverse outcomes following haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide: a two-center analysis
|
de Lima, Viviane Jesus Torres |
|
|
101 |
8 |
p. 1795-1802 |
artikel |
26 |
Sex differences in fatigue and symptoms of anemia in relation to hemoglobin level in hospitalized patients
|
Prochaska, Micah T. |
|
|
101 |
8 |
p. 1873-1875 |
artikel |
27 |
Significance of alveolar nitric oxide concentration in the airway of patients with organizing pneumonia after allogeneic hematopoietic stem cell transplantation
|
Kajimura, Yasuko |
|
|
101 |
8 |
p. 1803-1813 |
artikel |
28 |
Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol
|
Lobitz, Stephan |
|
|
101 |
8 |
p. 1859-1860 |
artikel |
29 |
Successful desensitization of high level donor-specific anti-HLA antibody in patients with hematological diseases receiving haploidentical allografts
|
Zheng, Xiaoli |
|
|
101 |
8 |
p. 1777-1783 |
artikel |
30 |
Thrombocytopenia, splenomegaly, and periportal fibrosis in a migrant
|
Phan, Timothy |
|
|
101 |
8 |
p. 1883-1884 |
artikel |
31 |
Thrombopoietin receptor agonist for treating bone marrow aplasia following anti-CD19 CAR-T cells—single-center experience
|
Beyar-Katz, Ofrat |
|
|
101 |
8 |
p. 1769-1776 |
artikel |
32 |
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis
|
Wolach, Ofir |
|
|
101 |
8 |
p. 1719-1726 |
artikel |